Abstract:ABSTRACT Bacillus anthracis causes anthrax through a combination of bacterial infection and toxemia. As a major virulence factor of B. anthracis , anthrax lethal toxin (LT) is a zinc-dependent metalloproteinase, exerting its cytotoxicity through proteolytic cleavage of the mitogen-activated protein kinase kinases, thereby shutting down the MAPK pathways. Anthrax lethal toxin induces host lethality mostly by targeting the cardiovascular system. Although the enzymatic activity and the molecular targets of LT have long been known, the detailed mechanisms underlying cellular/tissue/organ toxicity are still poorly understood. In this work, we sought to investigate the mechanism of LT-induced cellular damage in the cardiovascular system. We demonstrate for the first time that anthrax lethal toxin has potent inhibitory effects on the central metabolism of cardiomyocytes and endothelial cells. This is likely due to the observed downregulating of c-Myc expression through the toxin-induced inhibition of the ERK pathway. Since c-Myc is a master transcription factor controlling the expression of many rate-limiting metabolic enzymes in glycolysis and the tricarboxylic acid cycle, LT’s downregulation of c-Myc may lead to the observed bioenergetic collapse, particularly, in cardiomyocytes. Since cardiac cell contraction requires continuous production of large amounts of ATP, potent inhibition of the bioenergetics of cardiomyocytes would be incompatible with life. Thus, LT-induced lethality through targeting cardiomyocytes and endothelial cells appears to be a consequence of a bioenergetic collapse, likely due to the toxin’s potent inhibitory activity on the MEK-ERK-c-Myc-metabolic/bioenergetic axis within these target cells of cardiovascular system. IMPORTANCE Anthrax lethal toxin (LT) is a major virulence factor of Bacillus anthracis , the causative pathogen of anthrax disease. Anthrax lethal toxin is a metalloproteinase that cleaves and inactivates MEKs, thereby shutting down MAPK pathways, leading to host mortality primarily through targeting of the cardiovascular system. However, the detailed mechanisms underlying the toxin’s cellular and tissue toxicity are still poorly understood. Here, we found that anthrax lethal toxin has potent inhibitory activity on glycolysis and oxidative phosphorylation of cardiomyocytes and endothelial cells. These effects appear to be the consequence of downregulation of c-Myc, a master transcription factor that controls many rate-limiting enzymes of glycolysis and the tricarboxylic acid cycle. With the high demand on energy for cardiac contraction, the potent inhibition of cardiomyocyte metabolism by LT would be incompatible with life. This work provides critical insights into why the cardiovascular system is the major in vivo target of LT-induced lethality.

B. Anthracis Associated Cardiovascular Dysfunction and Shock: the Potential Contribution of Both Non-Toxin and Toxin Components

Bacillus Anthracis Edema Toxin Causes Extensive Tissue Lesions and Rapid Lethality in Mice

Advance in Toxic and Pathogenic Mechanisms of Bacterial Hemolysins

Anthrax Lethal Toxin Suppresses Murine Cardiomyocyte Contractile Function and Intracellular Ca2+ Handling Via a NADPH Oxidase-Dependent Mechanism.

Cardiac-Specific Catalase Overexpression Rescues Anthrax Lethal Toxin-Induced Cardiac Contractile Dysfunction: Role of Oxidative Stress and Autophagy

Anthrax lethal toxin exerts potent metabolic inhibition of the cardiovascular system

Progress in research on pathogenesis of Bacillus anthracis and vaccine design strategies

Direct Cardiovascular Implications of Emerging Infectious Diseases and Biological Terrorism Threats

Capsules, Toxins and AtxA as Virulence Factors of Emerging Bacillus cereus Biovar anthracis

Whole-Transcriptome Analysis Highlights Adenylyl Cyclase Toxins-Derived Modulation of NF-κB and ERK1/2 Pathways in Macrophages

Potential Role of Autophagy in the Bactericidal Activity of Human PMNs for Bacillus Anthracis.

Review of advances in molecular structure and biological function of alpha toxin of Clostridium perfringens

Anthrax lethal toxin and tumor necrosis factor-α synergize on intestinal epithelia to induce mouse death

Macrophages in the inflammatory response to endotoxic shock

Anthrax lethal toxin: a weapon of multisystem destruction

Toll-like receptor 4 knockout protects against anthrax lethal toxin-induced cardiac contractile dysfunction: role of autophagy.

Abstract 9083: Beta1-Adrenergic cAMP Signaling is Uncoupled after Acute Treatment of Anthrax Lethal Toxin in Cardiomyocytes in Normal Rats

Anthrax: Where Margins are Merging between Emerging Threats and Bioterrorism

Role of Intestinal Lymphatic Pathway in Pathogenesis of Intestine-Derived Bacteria/endotoxin Translocation in Rats in Shock

Intracellular Bacteriolysis Contributes to Pathogenicity of Staphylococcus Aureus by Exacerbating AIM2-mediated Inflammation and Necroptosis

Alternative pre-approved and novel therapies for the treatment of anthrax